nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—peripheral nervous system neoplasm	0.851	1	CbGaD
Succinylcholine—CHRNA10—internal ear—peripheral nervous system neoplasm	0.0117	0.435	CbGeAlD
Succinylcholine—CHRNG—tongue—peripheral nervous system neoplasm	0.0057	0.212	CbGeAlD
Succinylcholine—Decamethonium—BCHE—peripheral nervous system neoplasm	0.00431	1	CrCbGaD
Succinylcholine—CHRNA1—tongue—peripheral nervous system neoplasm	0.00377	0.141	CbGeAlD
Succinylcholine—CHRNG—trigeminal ganglion—peripheral nervous system neoplasm	0.00283	0.106	CbGeAlD
Succinylcholine—Rhabdomyolysis—Tretinoin—peripheral nervous system neoplasm	0.00205	0.0185	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.0185	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Melphalan—peripheral nervous system neoplasm	0.00202	0.0182	CcSEcCtD
Succinylcholine—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.00186	0.0168	CcSEcCtD
Succinylcholine—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.00185	0.0166	CcSEcCtD
Succinylcholine—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.00185	0.0166	CcSEcCtD
Succinylcholine—Pulmonary oedema—Tretinoin—peripheral nervous system neoplasm	0.00161	0.0145	CcSEcCtD
Succinylcholine—Pulmonary oedema—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.0145	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.014	CcSEcCtD
Succinylcholine—Renal failure acute—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.0128	CcSEcCtD
Succinylcholine—Renal failure acute—Tretinoin—peripheral nervous system neoplasm	0.00143	0.0128	CcSEcCtD
Succinylcholine—Renal failure acute—Melphalan—peripheral nervous system neoplasm	0.00141	0.0127	CcSEcCtD
Succinylcholine—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.0126	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.00137	0.0124	CcSEcCtD
Succinylcholine—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.00135	0.0122	CcSEcCtD
Succinylcholine—Apnoea—Etoposide—peripheral nervous system neoplasm	0.00127	0.0114	CcSEcCtD
Succinylcholine—Cardiac arrest—Topotecan—peripheral nervous system neoplasm	0.00126	0.0114	CcSEcCtD
Succinylcholine—Cardiac arrest—Tretinoin—peripheral nervous system neoplasm	0.00125	0.0113	CcSEcCtD
Succinylcholine—Cardiac arrest—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.0113	CcSEcCtD
Succinylcholine—Cardiac arrest—Melphalan—peripheral nervous system neoplasm	0.00124	0.0111	CcSEcCtD
Succinylcholine—Pulmonary oedema—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.011	CcSEcCtD
Succinylcholine—Hyperkalaemia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.0104	CcSEcCtD
Succinylcholine—CHRNE—ErbB2/ErbB3 signaling events—NF2—peripheral nervous system neoplasm	0.00114	0.163	CbGpPWpGaD
Succinylcholine—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00112	0.0101	CcSEcCtD
Succinylcholine—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.0101	CcSEcCtD
Succinylcholine—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.0011	0.00995	CcSEcCtD
Succinylcholine—Renal failure acute—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00974	CcSEcCtD
Succinylcholine—Renal failure—Isotretinoin—peripheral nervous system neoplasm	0.000997	0.00899	CcSEcCtD
Succinylcholine—Renal failure—Tretinoin—peripheral nervous system neoplasm	0.000997	0.00899	CcSEcCtD
Succinylcholine—Cardiac arrest—Alitretinoin—peripheral nervous system neoplasm	0.000949	0.00855	CcSEcCtD
Succinylcholine—Renal failure acute—Cisplatin—peripheral nervous system neoplasm	0.000921	0.0083	CcSEcCtD
Succinylcholine—Cardiac arrest—Vincristine—peripheral nervous system neoplasm	0.000914	0.00824	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.000878	0.00791	CcSEcCtD
Succinylcholine—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.000848	0.00764	CcSEcCtD
Succinylcholine—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.000845	0.00762	CcSEcCtD
Succinylcholine—Flushing—Tretinoin—peripheral nervous system neoplasm	0.000845	0.00762	CcSEcCtD
Succinylcholine—Flushing—Melphalan—peripheral nervous system neoplasm	0.000834	0.00752	CcSEcCtD
Succinylcholine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000814	0.00733	CcSEcCtD
Succinylcholine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000814	0.00733	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.000805	0.00725	CcSEcCtD
Succinylcholine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000803	0.00724	CcSEcCtD
Succinylcholine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000796	0.0297	CbGeAlD
Succinylcholine—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.000756	0.00681	CcSEcCtD
Succinylcholine—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.000741	0.00667	CcSEcCtD
Succinylcholine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000691	0.00623	CcSEcCtD
Succinylcholine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000685	0.00617	CcSEcCtD
Succinylcholine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000685	0.00617	CcSEcCtD
Succinylcholine—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000681	0.00613	CcSEcCtD
Succinylcholine—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000675	0.00608	CcSEcCtD
Succinylcholine—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000675	0.00608	CcSEcCtD
Succinylcholine—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000666	0.006	CcSEcCtD
Succinylcholine—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.000662	0.00597	CcSEcCtD
Succinylcholine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.000652	0.00588	CcSEcCtD
Succinylcholine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.000647	0.00583	CcSEcCtD
Succinylcholine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.000647	0.00583	CcSEcCtD
Succinylcholine—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.000644	0.0058	CcSEcCtD
Succinylcholine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.00577	CcSEcCtD
Succinylcholine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000639	0.00576	CcSEcCtD
Succinylcholine—Shock—Tretinoin—peripheral nervous system neoplasm	0.000637	0.00574	CcSEcCtD
Succinylcholine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000637	0.00574	CcSEcCtD
Succinylcholine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000632	0.00569	CcSEcCtD
Succinylcholine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000632	0.00569	CcSEcCtD
Succinylcholine—CHRNB1—cerebellum—peripheral nervous system neoplasm	0.000631	0.0235	CbGeAlD
Succinylcholine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000623	0.00562	CcSEcCtD
Succinylcholine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.00556	CcSEcCtD
Succinylcholine—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	0.000616	0.023	CbGeAlD
Succinylcholine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000605	0.00545	CcSEcCtD
Succinylcholine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000605	0.00545	CcSEcCtD
Succinylcholine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000599	0.0054	CcSEcCtD
Succinylcholine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000597	0.00538	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000594	0.00536	CcSEcCtD
Succinylcholine—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00532	CcSEcCtD
Succinylcholine—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00059	0.00532	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00059	0.00531	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00059	0.00531	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000584	0.00526	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000582	0.00524	CcSEcCtD
Succinylcholine—CHRNA1—ErbB2/ErbB3 signaling events—NF2—peripheral nervous system neoplasm	0.000576	0.0821	CbGpPWpGaD
Succinylcholine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000552	0.00497	CcSEcCtD
Succinylcholine—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.00493	CcSEcCtD
Succinylcholine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000546	0.00492	CcSEcCtD
Succinylcholine—BCHE—brainstem—peripheral nervous system neoplasm	0.000545	0.0203	CbGeAlD
Succinylcholine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00487	CcSEcCtD
Succinylcholine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000535	0.00482	CcSEcCtD
Succinylcholine—Hypertonia—Epirubicin—peripheral nervous system neoplasm	0.000527	0.00475	CcSEcCtD
Succinylcholine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000525	0.00473	CcSEcCtD
Succinylcholine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000519	0.00467	CcSEcCtD
Succinylcholine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000518	0.00467	CcSEcCtD
Succinylcholine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000516	0.00465	CcSEcCtD
Succinylcholine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000514	0.00463	CcSEcCtD
Succinylcholine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000514	0.00463	CcSEcCtD
Succinylcholine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.00461	CcSEcCtD
Succinylcholine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000512	0.00461	CcSEcCtD
Succinylcholine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000512	0.00461	CcSEcCtD
Succinylcholine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000507	0.00457	CcSEcCtD
Succinylcholine—Flushing—Etoposide—peripheral nervous system neoplasm	0.0005	0.00451	CcSEcCtD
Succinylcholine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.0005	0.0045	CcSEcCtD
Succinylcholine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.00446	CcSEcCtD
Succinylcholine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000493	0.00444	CcSEcCtD
Succinylcholine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00442	CcSEcCtD
Succinylcholine—Hypertonia—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.0044	CcSEcCtD
Succinylcholine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000483	0.00435	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000482	0.00434	CcSEcCtD
Succinylcholine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000481	0.00433	CcSEcCtD
Succinylcholine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000479	0.00431	CcSEcCtD
Succinylcholine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000477	0.0043	CcSEcCtD
Succinylcholine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000477	0.0043	CcSEcCtD
Succinylcholine—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000473	0.00426	CcSEcCtD
Succinylcholine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000473	0.00426	CcSEcCtD
Succinylcholine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000471	0.00424	CcSEcCtD
Succinylcholine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000458	0.00413	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000451	0.00406	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000447	0.00403	CcSEcCtD
Succinylcholine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000442	0.00398	CcSEcCtD
Succinylcholine—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.00394	CcSEcCtD
Succinylcholine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000436	0.00393	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000431	0.00388	CcSEcCtD
Succinylcholine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000418	0.00377	CcSEcCtD
Succinylcholine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000418	0.00377	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.00376	CcSEcCtD
Succinylcholine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000415	0.00374	CcSEcCtD
Succinylcholine—Rash—Topotecan—peripheral nervous system neoplasm	0.000411	0.00371	CcSEcCtD
Succinylcholine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000411	0.0037	CcSEcCtD
Succinylcholine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000408	0.00368	CcSEcCtD
Succinylcholine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.00368	CcSEcCtD
Succinylcholine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00367	CcSEcCtD
Succinylcholine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000408	0.00367	CcSEcCtD
Succinylcholine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.00367	CcSEcCtD
Succinylcholine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000405	0.00365	CcSEcCtD
Succinylcholine—Rash—Melphalan—peripheral nervous system neoplasm	0.000403	0.00363	CcSEcCtD
Succinylcholine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000402	0.00363	CcSEcCtD
Succinylcholine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00039	0.00352	CcSEcCtD
Succinylcholine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00039	0.00351	CcSEcCtD
Succinylcholine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.00351	CcSEcCtD
Succinylcholine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.00349	CcSEcCtD
Succinylcholine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.00346	CcSEcCtD
Succinylcholine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000383	0.00345	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000381	0.00343	CcSEcCtD
Succinylcholine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000374	0.00337	CcSEcCtD
Succinylcholine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000374	0.00337	CcSEcCtD
Succinylcholine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00326	CcSEcCtD
Succinylcholine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000358	0.00322	CcSEcCtD
Succinylcholine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000348	0.00314	CcSEcCtD
Succinylcholine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000334	0.003	CcSEcCtD
Succinylcholine—CHRM3—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000331	0.0472	CbGpPWpGaD
Succinylcholine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000331	0.00298	CcSEcCtD
Succinylcholine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00298	CcSEcCtD
Succinylcholine—CHRM2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000328	0.0468	CbGpPWpGaD
Succinylcholine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00279	CcSEcCtD
Succinylcholine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00278	CcSEcCtD
Succinylcholine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00277	CcSEcCtD
Succinylcholine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00277	CcSEcCtD
Succinylcholine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.00276	CcSEcCtD
Succinylcholine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000304	0.00274	CcSEcCtD
Succinylcholine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000303	0.00273	CcSEcCtD
Succinylcholine—Rash—Vincristine—peripheral nervous system neoplasm	0.000298	0.00268	CcSEcCtD
Succinylcholine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000298	0.00268	CcSEcCtD
Succinylcholine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00256	CcSEcCtD
Succinylcholine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000282	0.00254	CcSEcCtD
Succinylcholine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00253	CcSEcCtD
Succinylcholine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00243	CcSEcCtD
Succinylcholine—BCHE—cerebellum—peripheral nervous system neoplasm	0.000269	0.01	CbGeAlD
Succinylcholine—CHRNE—ErbB2/ErbB3 signaling events—PTPN11—peripheral nervous system neoplasm	0.000266	0.0379	CbGpPWpGaD
Succinylcholine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00237	CcSEcCtD
Succinylcholine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00237	CcSEcCtD
Succinylcholine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.00234	CcSEcCtD
Succinylcholine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00225	CcSEcCtD
Succinylcholine—Rash—Etoposide—peripheral nervous system neoplasm	0.000241	0.00217	CcSEcCtD
Succinylcholine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000241	0.00217	CcSEcCtD
Succinylcholine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00205	CcSEcCtD
Succinylcholine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00202	CcSEcCtD
Succinylcholine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00193	CcSEcCtD
Succinylcholine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000211	0.0019	CcSEcCtD
Succinylcholine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00189	CcSEcCtD
Succinylcholine—CHRNE—ErbB2/ErbB3 signaling events—ERBB2—peripheral nervous system neoplasm	0.00021	0.0299	CbGpPWpGaD
Succinylcholine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00189	CcSEcCtD
Succinylcholine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00187	CcSEcCtD
Succinylcholine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00181	CcSEcCtD
Succinylcholine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00179	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00176	CcSEcCtD
Succinylcholine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00176	CcSEcCtD
Succinylcholine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00175	CcSEcCtD
Succinylcholine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00167	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00163	CcSEcCtD
Succinylcholine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00154	CcSEcCtD
Succinylcholine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00017	0.00153	CcSEcCtD
Succinylcholine—CHRNE—ErbB2/ErbB3 signaling events—NRAS—peripheral nervous system neoplasm	0.00016	0.0228	CbGpPWpGaD
Succinylcholine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00142	CcSEcCtD
Succinylcholine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00142	CcSEcCtD
Succinylcholine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00141	CcSEcCtD
Succinylcholine—CHRNG—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000149	0.0213	CbGpPWpGaD
Succinylcholine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00132	CcSEcCtD
Succinylcholine—CHRNE—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00014	0.02	CbGpPWpGaD
Succinylcholine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00122	CcSEcCtD
Succinylcholine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00122	CcSEcCtD
Succinylcholine—CHRNA1—ErbB2/ErbB3 signaling events—PTPN11—peripheral nervous system neoplasm	0.000134	0.0191	CbGpPWpGaD
Succinylcholine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00113	CcSEcCtD
Succinylcholine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00113	CcSEcCtD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000122	0.0175	CbGpPWpGaD
Succinylcholine—CHRNE—ErbB2/ErbB3 signaling events—HRAS—peripheral nervous system neoplasm	0.000117	0.0167	CbGpPWpGaD
Succinylcholine—CHRNG—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000114	0.0163	CbGpPWpGaD
Succinylcholine—CHRNE—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000107	0.0153	CbGpPWpGaD
Succinylcholine—CHRNA1—ErbB2/ErbB3 signaling events—ERBB2—peripheral nervous system neoplasm	0.000106	0.0151	CbGpPWpGaD
Succinylcholine—CHRNE—ErbB2/ErbB3 signaling events—AKT1—peripheral nervous system neoplasm	0.000103	0.0147	CbGpPWpGaD
Succinylcholine—CHRND—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	8.3e-05	0.0118	CbGpPWpGaD
Succinylcholine—CHRNA1—ErbB2/ErbB3 signaling events—NRAS—peripheral nervous system neoplasm	8.04e-05	0.0115	CbGpPWpGaD
Succinylcholine—CHRNA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	7.05e-05	0.0101	CbGpPWpGaD
Succinylcholine—CHRND—Neuronal System—BCHE—peripheral nervous system neoplasm	6.36e-05	0.00906	CbGpPWpGaD
Succinylcholine—CHRNA1—ErbB2/ErbB3 signaling events—HRAS—peripheral nervous system neoplasm	5.88e-05	0.00838	CbGpPWpGaD
Succinylcholine—CHRM1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	5.88e-05	0.00838	CbGpPWpGaD
Succinylcholine—CHRM3—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	5.86e-05	0.00835	CbGpPWpGaD
Succinylcholine—CHRM3—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	5.82e-05	0.0083	CbGpPWpGaD
Succinylcholine—CHRNA1—Neuronal System—BCHE—peripheral nervous system neoplasm	5.4e-05	0.0077	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	5.26e-05	0.0075	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	5.24e-05	0.00747	CbGpPWpGaD
Succinylcholine—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—peripheral nervous system neoplasm	5.19e-05	0.0074	CbGpPWpGaD
Succinylcholine—CHRM3—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	4.68e-05	0.00668	CbGpPWpGaD
Succinylcholine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.65e-05	0.00663	CbGpPWpGaD
Succinylcholine—CHRM3—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	4.58e-05	0.00652	CbGpPWpGaD
Succinylcholine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.38e-05	0.00624	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.33e-05	0.00617	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.89e-05	0.00555	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.88e-05	0.00553	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	3.84e-05	0.00548	CbGpPWpGaD
Succinylcholine—CHRM3—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	3.68e-05	0.00525	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	3.52e-05	0.00502	CbGpPWpGaD
Succinylcholine—CHRNG—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.5e-05	0.00499	CbGpPWpGaD
Succinylcholine—CHRNE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.29e-05	0.00469	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	3.23e-05	0.0046	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.97e-05	0.00423	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.96e-05	0.00421	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	2.93e-05	0.00417	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.85e-05	0.00407	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.84e-05	0.00405	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.83e-05	0.00404	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	2.81e-05	0.004	CbGpPWpGaD
Succinylcholine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.77e-05	0.00395	CbGpPWpGaD
Succinylcholine—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.76e-05	0.00394	CbGpPWpGaD
Succinylcholine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	2.74e-05	0.0039	CbGpPWpGaD
Succinylcholine—CHRNG—Neuronal System—HRAS—peripheral nervous system neoplasm	2.68e-05	0.00382	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	2.67e-05	0.00381	CbGpPWpGaD
Succinylcholine—CHRM1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	2.64e-05	0.00377	CbGpPWpGaD
Succinylcholine—CHRM3—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	2.63e-05	0.00375	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	2.63e-05	0.00375	CbGpPWpGaD
Succinylcholine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.59e-05	0.00369	CbGpPWpGaD
Succinylcholine—CHRNE—Neuronal System—HRAS—peripheral nervous system neoplasm	2.52e-05	0.00359	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	2.38e-05	0.00339	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	2.36e-05	0.00337	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	2.36e-05	0.00336	CbGpPWpGaD
Succinylcholine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	2.2e-05	0.00314	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.19e-05	0.00313	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	2.17e-05	0.0031	CbGpPWpGaD
Succinylcholine—CHRND—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.95e-05	0.00277	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.93e-05	0.00275	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	1.9e-05	0.00271	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.75e-05	0.00249	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.74e-05	0.00249	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	1.73e-05	0.00246	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.68e-05	0.00239	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.67e-05	0.00238	CbGpPWpGaD
Succinylcholine—CHRNA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.65e-05	0.00236	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	1.65e-05	0.00236	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.52e-05	0.00217	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.52e-05	0.00216	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.5e-05	0.00214	CbGpPWpGaD
Succinylcholine—CHRND—Neuronal System—HRAS—peripheral nervous system neoplasm	1.49e-05	0.00213	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.48e-05	0.00211	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.46e-05	0.00208	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.45e-05	0.00207	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.44e-05	0.00205	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.44e-05	0.00205	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	1.43e-05	0.00204	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—GNS—peripheral nervous system neoplasm	1.39e-05	0.00199	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NME1—peripheral nervous system neoplasm	1.34e-05	0.0019	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.33e-05	0.0019	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.33e-05	0.00189	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	1.32e-05	0.00187	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.31e-05	0.00187	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—COX2—peripheral nervous system neoplasm	1.29e-05	0.00183	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.27e-05	0.00181	CbGpPWpGaD
Succinylcholine—CHRNA1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.27e-05	0.00181	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.27e-05	0.0018	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	1.25e-05	0.00179	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.17e-05	0.00166	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.16e-05	0.00166	CbGpPWpGaD
Succinylcholine—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	1.16e-05	0.00165	CbGpPWpGaD
Succinylcholine—CHRM3—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	1.15e-05	0.00164	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.15e-05	0.00164	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.15e-05	0.00164	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.15e-05	0.00164	CbGpPWpGaD
Succinylcholine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	1.14e-05	0.00163	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.14e-05	0.00162	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GNS—peripheral nervous system neoplasm	1.07e-05	0.00153	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.06e-05	0.00152	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.06e-05	0.00151	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.05e-05	0.0015	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NME1—peripheral nervous system neoplasm	1.03e-05	0.00146	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—COX2—peripheral nervous system neoplasm	9.89e-06	0.00141	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.99e-06	0.00128	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.96e-06	0.00128	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.87e-06	0.00126	CbGpPWpGaD
Succinylcholine—BCHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	8.68e-06	0.00124	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.63e-06	0.00123	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.62e-06	0.00123	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.61e-06	0.00123	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.59e-06	0.00122	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.51e-06	0.00121	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ENO2—peripheral nervous system neoplasm	8.44e-06	0.0012	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.53e-06	0.00107	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.51e-06	0.00107	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.43e-06	0.00106	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.97e-06	0.000993	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.84e-06	0.000975	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.82e-06	0.000972	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.81e-06	0.000971	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.81e-06	0.00097	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.79e-06	0.000968	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.75e-06	0.000962	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.73e-06	0.000959	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—TH—peripheral nervous system neoplasm	6.71e-06	0.000956	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—HRAS—peripheral nervous system neoplasm	6.65e-06	0.000947	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.58e-06	0.000939	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.56e-06	0.000936	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.5e-06	0.000926	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	6.49e-06	0.000925	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.32e-06	0.0009	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.3e-06	0.000897	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.29e-06	0.000896	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.27e-06	0.000893	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.21e-06	0.000885	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.98e-06	0.000852	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.96e-06	0.00085	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.9e-06	0.000841	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	5.49e-06	0.000782	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—GNAS—peripheral nervous system neoplasm	5.48e-06	0.000781	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ABCB1—peripheral nervous system neoplasm	5.37e-06	0.000766	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.23e-06	0.000746	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	5.16e-06	0.000735	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.72e-06	0.000673	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.71e-06	0.000671	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.66e-06	0.000664	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	4.21e-06	0.0006	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.16e-06	0.000592	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.14e-06	0.00059	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	4.13e-06	0.000589	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.1e-06	0.000585	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.04e-06	0.000576	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.03e-06	0.000574	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.99e-06	0.000568	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.85e-06	0.000549	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.84e-06	0.000547	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.8e-06	0.000542	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.53e-06	0.000503	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.52e-06	0.000502	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.49e-06	0.000497	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.5e-06	0.000356	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.49e-06	0.000355	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.47e-06	0.000352	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.45e-06	0.00035	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.45e-06	0.000349	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.42e-06	0.000345	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.94e-06	0.000277	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.93e-06	0.000276	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.92e-06	0.000273	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.83e-06	0.000261	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.82e-06	0.00026	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.8e-06	0.000257	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.78e-06	0.000253	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.77e-06	0.000253	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.76e-06	0.000251	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.76e-06	0.00025	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.75e-06	0.00025	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.74e-06	0.000248	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.61e-06	0.00023	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.61e-06	0.000229	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.59e-06	0.000227	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—peripheral nervous system neoplasm	1.48e-06	0.000211	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.48e-06	0.00021	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.47e-06	0.00021	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.46e-06	0.000208	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.37e-06	0.000196	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.37e-06	0.000195	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.36e-06	0.000193	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-06	0.000162	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.13e-06	0.000161	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.13e-06	0.00016	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.11e-06	0.000159	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.08e-06	0.000154	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.08e-06	0.000153	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.07e-06	0.000152	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.53e-07	0.000136	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.5e-07	0.000135	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.41e-07	0.000134	CbGpPWpGaD
